• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    MICRO Expands with New Facility in Costa Rica

    DiaSorin to Buy Luminex for $1.8B

    Endologix Acquires PQ Bypass

    Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems

    Elixir Medical Begins Study of Metallic Implant for CAD Treatment
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Trademark Plastics Inc.

    Medicoil

    MW Life Sciences

    K-Tube Technologies

    PTI Engineered Plastics Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing

    Digging into the Cardiac Arrhythmia Monitoring Device Market
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    Concise Engineering

    Qosina Corp.

    MW Life Sciences

    Medicoil
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Quality Assurance When Supply Chain Disruptions Arise

    From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.

    Related CONTENT
    • A Digital Stethoscope & Digital Health—A Medtech Matters Podcast
    • Why Use a Medical Grade Silicone for Your Components?
    • Three Future Trends and Opportunities in Quality Assurance
    • Adopting a Data-Driven Quality Model
    • USPTO Issues Patent Covering Hancock Jaffe’s VenoValve
    Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing11.04.20
    From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020. While many in the industry are working in overdrive to keep projects on track, the regulatory landscape can shift day-to-day, making it challenging to keep up with best practices for gaining or maintaining regulatory approval. To avoid setbacks with compliance, medical device manufacturers should strive to anticipate potential challenges and institute proactive measures.

    Companies can begin to identify where a device may face risks by first looking into the sources that can cause complications and delays. Changes to device design, the manufacturing process, or the supply chain can present challenges when seeking regulatory approval. To achieve the highest level of quality assurance, companies should dedicate time to identifying each obstacle and develop precautions to stay ahead of any increases in risk.

    Managing Material Needs
    Backlogged supply deliveries in the past year have led to a widespread desire to move to onshore sourcing. From decreased capacity to transportation slowdowns, the limited availability of certain materials has made it difficult to maintain adequate supplies for production. These challenges, paired with the increasing scrutiny of materials with the publication of ISO 10993-18:2020, can create obstacles for device manufacturers trying to protect the quality, performance, and safety of their products during development and beyond.

    Before material needs escalate, companies should consider a proactive approach to maintaining production. They can start by evaluating the risks of adding more safety stock compared to the likelihood of future shortages. If expanding safety stock presents fewer risks and is actionable financially, this should be a manufacturer’s primary step to managing future material needs. This is an especially important step for small to mid-sized manufacturers that might face increased challenges in purchasing due to their comparative lack of scale.

    If safety stock doesn’t resolve issues with material sourcing, companies can brainstorm creative uses for work-in-progress materials. Utilizing what is available in unique ways could yield additional time to investigate future solutions more thoroughly. For example, if the same material is used across multiple products, discontinuing the manufacturing of a less profitable or in-demand product can allow for materials to be used for more critical devices.

    Additionally, working with materials that have an established history in the device’s production process can reduce new variables of risk. In general, companies should encourage the use of proven materials with a history of testing with labs and regulatory bodies whenever possible. Novel materials may be at higher risk of scrutiny and unsatisfactory outcomes among regulators in risk assessments, where proven materials help minimize the likelihood of these setbacks.

    Ensuring Production Quality
    Whether scaling up, down, or maintaining production, most manufacturers have had to ask themselves tough questions about how best to utilize their investments and facilities, both now and in the long term. Not only is there interest in switching to domestic suppliers, but there’s also interest in the strategy of moving manufacturing sites onshore. Taking a more measured approach can help ensure the quality from development through the entire product lifecycle.

    Evaluating the production process starts with a risk analysis to determine if changes will require additional testing. Changes to manufacturing, such as moving locations or changing cleaning agents, cannot be overlooked—no matter how seemingly insignificant they are. Identifying the risks associated with these changes before implementing them provides an opportunity to involve the right parties ahead of time to address necessary compliance precautions and avoid over-testing.

    Capacity constraints aren’t limited to manufacturers but can extend beyond the supply chain to testing labs. For example, it’s possible that testing labs won’t have the ability to be as responsive to requests for quick turnaround times as they have in the past. Particularly with higher risk or more invasive devices, even minor changes can create the need for a full chemical characterization study. Having an ongoing dialogue and a strong relationship with testing partners can help level-set expectations for testing timelines and planning needs.

    Special considerations for 3D printers
    The use of 3D printers is becoming more widespread as a potential solution to help fill the gaps manufacturers experience with production. However, safety standards for this method of production are unclear. In the past, regulators faced challenges in developing consistent standards for 3D-printed medical devices or components. Manufacturers advocating for the use of 3D printers should consult with their regulatory body to ensure patient safety and quality assurance.

    Without an exact blueprint to follow for 3D printing materials and the testing that follows, the process starts by taking steps such as selecting transparent material suppliers and gathering as much data on the materials as possible. Creating a paper trail helps build a solid foundation for reference during the risk analysis. Finally, this information can be useful to develop a testing plan customized to the risks at hand, as uniform testing is not yet an option. By working closely with a testing lab, compliance groups, and regulatory bodies, medical device manufacturers can ensure that everyone is on the same page and anticipate any potential setbacks.

    Selecting Partners
    The challenges manufacturers face in remaining streamlined and efficient apply to their partner organizations, too. Production partners should be selected carefully and thoughtfully. Companies engaging additional testing or manufacturing partners and/or working with regulatory agencies should start the process early, even if the product isn’t yet available, as shipping delays might occur.

    In a largely “work-from-home” world, many manufacturers have had to become more inventive in conducting quality audits. Virtual audits are now more commonplace. For larger companies, there may be options to leverage previously approved partners used in other divisions. Utilizing audits completed by another division within the company could abridge the necessary vetting procedures and save valuable time and money.

    Conversely, companies can also consider using current partners in new ways. For example, a manufacturer that relies on an outsourced testing lab for gathering biocompatibility data could get more mileage out of the partnership by also using the lab for an additional service like chemistry (if offered). With a previous facility audit already approved, this experience could lead to a more streamlined qualification process for other services or sites.

    When working with any partner, new or established, it’s essential to understand their functionality in response to global conditions and how that could impact projects. One area susceptible to increased activity is information technology (IT) infrastructures, which could be under strain as teams try to adequately support new working conditions. In regards to testing in areas like chemistry, if the investment in the IT supporting this function isn’t significant, data processing and results could face delays. Finding partners with proven quality and updated technology can help ensure timely project delivery.

    Understanding the Manufacturer’s Role
    Staying ahead of quality assurance risks may seem like a daunting task but in the long run, it can save time and possibly avoid regulatory setbacks or patient safety issues. Discovering the cause of complications and involving the right parties is the basis for successful management. Still, there are some steps that must be taken to help companies adhere to product development timelines.

    First, manufacturers should involve the procurement team in their development conversations, especially when discussing sourcing materials. Companies often won’t use a single source for all their materials and could be considering three or more vendors. The procurement team can help assess possible risks while evaluating the necessary capabilities in the production process.

    Next, gather all information including test reports, field reports and material information to perform a new risk assessment. Regulatory standards are continually evolving, and the testing performed on a device even 12 months prior may not be up to standards. If a company isn’t using comparable data during a risk analysis, it could be evaluating apples to oranges.

    Finally, taking note of process changes and their effectiveness is key to gaining the most value from potential change. Many in the industry are monitoring their responses to the current environment to inform future decisions. From discovering new capabilities with remote working, re-evaluating supply chains or navigating new partner auditing processes, there is potential to recognize opportunities for further efficiencies. Companies can take setbacks from recent events and use what they’ve learned to shape their business strategy going forward.

    Bringing medical devices to market and maintaining the compliance of existing devices is a time-consuming responsibility, even when everything goes according to plan. Fortunately, involving the right partners early in the process and throughout development can help close gaps and expand team knowledge. If medical device companies dedicate time to identifying obstacles and proactive planning, achieving the highest level of quality assurance can be much more attainable. 


    Sandi Schaible is the senior director of analytical chemistry and regulatory toxicology at WuXi AppTec Medical Device Testing, located in St. Paul, Minn., specializing in extractables and leachables studies. She is a U.S. delegate and international delegate for ISO 10993 part 18 in chemical characterization, and also a U.S. delegate for ISO 10993 part 13 and the particulates committee (TIR42).

    Peter Steen received his B.S. in chemistry and M.S in civil engineering from the University of Minnesota. His expertise includes chromatographic method development and validation, raw materials testing, medical device testing, and mass spectrometry. Since 2014 he’s worked in the area of extractables/leachables testing at WuXi AppTec Medical Device Testing and serves as a subject matter expert in gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) analyses.
    Suggested For You
    A Digital Stethoscope & Digital Health—A Medtech Matters Podcast A Digital Stethoscope & Digital Health—A Medtech Matters Podcast
    Why Use a Medical Grade Silicone for Your Components? Why Use a Medical Grade Silicone for Your Components?
    Three Future Trends and Opportunities in Quality Assurance Three Future Trends and Opportunities in Quality Assurance
    Adopting a Data-Driven Quality Model Adopting a Data-Driven Quality Model
    USPTO Issues Patent Covering Hancock Jaffe’s VenoValve USPTO Issues Patent Covering Hancock Jaffe’s VenoValve
    Viant Completes Expansion of Costa Rica Facility Viant Completes Expansion of Costa Rica Facility
    Digging into the Cardiac Arrhythmia Monitoring Device Market Digging into the Cardiac Arrhythmia Monitoring Device Market
    SMC Ltd. Expands Costa Rica Facility SMC Ltd. Expands Costa Rica Facility
    Berlin Heals Berlin Heals' C-MIC Heart Failure Implant Achieves Breakthrough Device Status
    Cloud and AI Accelerating Global Medical Imaging Informatics Market Cloud and AI Accelerating Global Medical Imaging Informatics Market
    Non-Dilutive Funding—A Medtech Matters Podcast Non-Dilutive Funding—A Medtech Matters Podcast
    Grant Issued for Development of 3D-Printed Resorbable Medical Implants Grant Issued for Development of 3D-Printed Resorbable Medical Implants
    Philips Survey Reveals COVID-19’s Negative Impact on Sleep Quality, CPAP Use Philips Survey Reveals COVID-19’s Negative Impact on Sleep Quality, CPAP Use
    Second Sight Aborts Business Combination with Pixium Vision Second Sight Aborts Business Combination with Pixium Vision
    BD to Invest $65M in Tucson, Arizona Supply Chain Hub BD to Invest $65M in Tucson, Arizona Supply Chain Hub

    Related Columns

    • Cardiovascular | Surgical
      Home Is Where the Heart (Valve) Is

      Home Is Where the Heart (Valve) Is

      Artificial heart valve makers reached a number of milestones despite the pandemic’s global squeeze.
      Sam Brusco, Associate Editor 04.01.21

    • Chronic Disease | Digital Health | Patient Monitoring
      CGM: Digital Health Meets a Very Large Opportunity

      CGM: Digital Health Meets a Very Large Opportunity

      Continuous glucose monitors (CGMs) are one of the most formidable diabetes management tools to be developed in decades.
      Maria Shepherd, President and Founder, Medi-Vantage 04.01.21

    • Surgical
      Biomechanical Engineer, Heal Thyself

      Biomechanical Engineer, Heal Thyself

      Choosing a treatment option for spinal disorders can be tricky with extensive knowledge of the industry.
      Dawn A. Lissy, Founder & President, Empirical 04.01.21


    • Molding | Surgical
      Optimizing MIM in Medical Device Manufacturing

      Optimizing MIM in Medical Device Manufacturing

      Metal injection molding (MIM) is a good choice for producing medium- to high-volume medtech parts.
      Steve Santoro, Executive Vice President, MICRO 04.01.21

    • Diagnostics
      PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market

      PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market

      With smart onshoring strategies, the medical device industry can collaborate to fix supply chain issues.
      Claudio Hanna and Ralph Tricomi , Web Industries 04.01.21

    • Testing
      The Evolution of Chemical Characterization for Medical Devices

      The Evolution of Chemical Characterization for Medical Devices

      Evaluation of biological safety of devices is experiencing some of the most significant changes in history.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec Medical Device Testing 04.01.21


    • Digital Health
      How Digital Health Fits into the Medtech Mold

      How Digital Health Fits into the Medtech Mold

      Healthcare will need to adopt digital technologies that streamline and enhance connectivity.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 04.01.21

    • Global Supply Chain Wisdom from Coronavirus-Colored Lenses

      Global Supply Chain Wisdom from Coronavirus-Colored Lenses

      There are precious pearls of wisdom from this past year that will come in handy during the next “crisis.”
      Chris Oleksy, Founder and CEO, Oleksy Enterprises and Co-Founder Next Life Medical; CEO, Emergent Respiratory 04.01.21

    • Four Considerations When Selling to a Private Equity Fund

      Four Considerations When Selling to a Private Equity Fund

      A private equity partner can help medtech firms expand into new markets and serve existing clients better.
      Bill Hadler and Anisa Mohanty, McDermott Will & Emery 04.01.21


    • Software & IT
      Cybersecurity Compromises, Courtesy of COVID-19

      Cybersecurity Compromises, Courtesy of COVID-19

      As the healthcare industry focused its energies last year on battling SARS-CoV-2, cybercriminals used the distraction to their advantage.
      Michael Barbella, Managing Editor 03.04.21

    • A Look at the Actual Device Costs for Hospitals

      A Look at the Actual Device Costs for Hospitals

      According to a 2018 clinical journal article, U.S. hospitals spent approximately $200 billion on medical devices.
      Maria Shepherd, President and Founder, Medi-Vantage 03.04.21

    • Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

      Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

      For small businesses, trade shows are a critical part of developing new business as well as maintaining contacts.
      Dawn A. Lissy, Founder & President, Empirical 03.04.21


    • FDA Making Progress With Technology and Data Action Plans

      FDA Making Progress With Technology and Data Action Plans

      There is an urgent need to get advanced technologies into the healthcare ecosystem, but all products must first get regulatory approval.
      Alan Rencher, Vice President, Engineering, MasterControl 03.04.21

    • What’s Hot Now in Medtech M&A

      What’s Hot Now in Medtech M&A

      Every M&A cycle in the life sciences/medtech sector fosters exciting deals that interestingly impact the industry in both the short and long term.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 03.04.21

    • Software & IT
      Three Ways to Fast-Track the Total Product Lifecycle

      Three Ways to Fast-Track the Total Product Lifecycle

      Here are three ways leaders including Alcon, Baxter Healthcare, Boston Scientific, Epredia, and Illumina are driving innovation in medtech.
      Seth Goldenberg, Ph.D., Vice President, MedTech, Veeva Systems 03.04.21


    Trending
    • Endologix Acquires PQ Bypass
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • DiaSorin To Buy Luminex For $1.8B
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Avantor To Acquire Ritter GmbH And Affiliates For $1B
    Breaking News
    • MICRO Expands with New Facility in Costa Rica
    • DiaSorin to Buy Luminex for $1.8B
    • Endologix Acquires PQ Bypass
    • Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems
    • Elixir Medical Begins Study of Metallic Implant for CAD Treatment
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    4-week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    Review Covers Role of Vitamin K2 in the ‘Calcium Paradox’
    KD Pharma Acquires Rohner AG Manufacturing Assets
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    Sika Expands Production Capacity in Qatar
    Sto Corp. ISO Certifications Extended
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MICRO Expands with New Facility in Costa Rica
    DiaSorin to Buy Luminex for $1.8B
    Endologix Acquires PQ Bypass
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Catalent Biologics Completes Madison Expansion
    Lonza Expands PyroTec PRO for Endotoxin Testing
    FDA Accepts Airway Therapeutics’ IND for COVID Treatment
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revieve Launches Skin Coach
    Carlyle Group Acquires Majority Stake in Beautycounter
    The Honest Co. Files for an Initial Public Offering
    Happi

    Latest Breaking News From Happi

    Babor Professional Skin Care Names McCaffrey as Vice President of Sales
    Diamond Chemical Appoints Technical Service Representative
    Carlyle To Acquire Majority Stake in Beautycounter
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Enprom helps converter respond to flexible packaging needs
    anytron assists medical device company with labeling
    Dantex debuts new capabilities with white ink opacity
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Aries Face Masks Meet ASTM Standards
    Tufropes Launches Inherently Antibacterial and Antimicrobial Spunbond
    NXTNano Adding Three Lines
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device
    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    First Solar Series 6 CuRe has Industry’s Lowest Warranted Degradation Rate
    SEMI: 2020 Global Semiconductor Equipment Sales Surge 19% to Industry Record $71.2 Billion

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login